share_log

4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

4：持股变动声明-董事 YALE PHYLLIS R
美股sec公告 ·  07/02 17:32
Moomoo AI 已提取核心信息
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has been involved in a transaction with the company's stock on June 30, 2024. The specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and there is no information provided about the number of shares held after the action.
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has been involved in a transaction with the company's stock on June 30, 2024. The specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and there is no information provided about the number of shares held after the action.
Bristol-Myers Squibb Co.（BMY）的报告人Phyllis R. Yale于2024年6月30日参与了该公司股票的交易。关于交易性质的具体细节，包括股票数量、交易价格和总价值，在公告中未予披露。Yale与发行人的关系未被特别说明，对行动后持有的股份数量也没有提供任何信息。
Bristol-Myers Squibb Co.（BMY）的报告人Phyllis R. Yale于2024年6月30日参与了该公司股票的交易。关于交易性质的具体细节，包括股票数量、交易价格和总价值，在公告中未予披露。Yale与发行人的关系未被特别说明，对行动后持有的股份数量也没有提供任何信息。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息